Adjuvant Denosumab Fails to Reduce Recurrences, Deaths in Early Breast Cancer

The D-CARE study found adjuvant denosumab is devoid of benefits in high-risk early breast cancer.

Source: CancerNetwork - June 11, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news